{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:44:23Z","timestamp":1788479063206,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021YFA1300900"],"award-info":[{"award-number":["2021YFA1300900"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973372"],"award-info":[{"award-number":["81973372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300152"],"award-info":[{"award-number":["32300152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M723164"],"award-info":[{"award-number":["2022M723164"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","award":["SKLRD-Z-202414"],"award-info":[{"award-number":["SKLRD-Z-202414"]}],"id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","award":["SKLRD-Z-202301"],"award-info":[{"award-number":["SKLRD-Z-202301"]}],"id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08646-z","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:40:05Z","timestamp":1755110405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mutations in ClpC1 or ClpX subunit of caseinolytic protease confer resistance to ilamycins in mycobacteria"],"prefix":"10.1038","volume":"8","author":[{"given":"Yamin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M. Adnan","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-8027","authenticated-orcid":false,"given":"Jianhua","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanshan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-7291","authenticated-orcid":false,"given":"Junying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-9122","authenticated-orcid":false,"given":"Xiaoli","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-6014","authenticated-orcid":false,"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"8646_CR1","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/resp.13393","volume":"23","author":"P Miotto","year":"2018","unstructured":"Miotto, P., Zhang, Y., Cirillo, D. M. & Yam, W. C. Drug resistance mechanisms and drug susceptibility testing for tuberculosis. Respirology 23, 1098\u20131113 (2018).","journal-title":"Respirology"},{"key":"8646_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","volume":"10","author":"K Dheda","year":"2024","unstructured":"Dheda, K. et al. Multidrug-resistant tuberculosis. Nat. Rev. Dis. Prim. 10, 22 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"8646_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep45258","volume":"7","author":"T Fedrizzi","year":"2017","unstructured":"Fedrizzi, T. et al. Genomic characterization of nontuberculous mycobacteria. Sci. Rep. 7, 45258 (2017).","journal-title":"Sci. Rep."},{"key":"8646_CR4","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.drudis.2018.04.001","volume":"23","author":"M-L Wu","year":"2018","unstructured":"Wu, M.-L., Aziz, D. B., Dartois, V. & Dick, T. NTM drug discovery: status, gaps and the way forward. Drug Discov. Today 23, 1502\u20131519 (2018).","journal-title":"Drug Discov. Today"},{"key":"8646_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10295-015-1709-3","volume":"43","author":"H Lee","year":"2016","unstructured":"Lee, H. & Suh, J. W. Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1. J. Ind. Microbiol. Biotechnol. 43, 205\u2013212 (2016).","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"8646_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1021\/acsinfecdis.7b00231","volume":"4","author":"TJ Lupoli","year":"2018","unstructured":"Lupoli, T. J., Vaubourgeix, J., Burns-Huang, K. & Gold, B. Targeting the proteostasis network for mycobacterial drug discovery. ACS Infect. Dis. 4, 478\u2013498 (2018).","journal-title":"ACS Infect. Dis."},{"key":"8646_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ab.2018.12.004","volume":"567","author":"H Fraga","year":"2019","unstructured":"Fraga, H. et al. Development of high throughput screening methods for inhibitors of ClpC1P1P2 from Mycobacteria tuberculosis. Anal. Biochem. 567, 30\u201337 (2019).","journal-title":"Anal. Biochem."},{"key":"8646_CR8","doi-asserted-by":"publisher","first-page":"eabn7943","DOI":"10.1126\/sciadv.abn7943","volume":"8","author":"FB d\u2019Andrea","year":"2022","unstructured":"d\u2019Andrea, F. B. et al. The essential M. tuberculosis Clp protease is functionally asymmetric in vivo. Sci. Adv. 8, eabn7943 (2022).","journal-title":"Sci. Adv."},{"key":"8646_CR9","doi-asserted-by":"publisher","first-page":"166815","DOI":"10.1016\/j.jmb.2021.166815","volume":"433","author":"P Texier","year":"2021","unstructured":"Texier, P. et al. ClpXP-mediated degradation of the TAC antitoxin is neutralized by the SecB-like chaperone in Mycobacterium tuberculosis. J. Mol. Biol. 433, 166815 (2021).","journal-title":"J. Mol. Biol."},{"key":"8646_CR10","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/emboj.2012.5","volume":"31","author":"T Akopian","year":"2012","unstructured":"Akopian, T. et al. The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring. EMBO J. 31, 1529\u20131541 (2012).","journal-title":"EMBO J."},{"key":"8646_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002511","volume":"8","author":"RM Raju","year":"2012","unstructured":"Raju, R. M. et al. Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection. PLoS Pathog. 8, e1002511 (2012).","journal-title":"PLoS Pathog."},{"key":"8646_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","volume":"48","author":"CM Sassetti","year":"2003","unstructured":"Sassetti, C. M., Boyd, D. H. & Rubin, E. J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48, 77\u201384 (2003).","journal-title":"Mol. Microbiol."},{"key":"8646_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/ph17020211","volume":"17","author":"HI Boshoff","year":"2024","unstructured":"Boshoff, H. I., Malhotra, N., Barry, C. E. III & Oh, S. The antitubercular activities of natural products with fused-nitrogen-containing heterocycles. Pharmaceuticals 17, 211 (2024).","journal-title":"Pharmaceuticals"},{"key":"8646_CR14","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1002\/anie.201101740","volume":"50","author":"EK Schmitt","year":"2011","unstructured":"Schmitt, E. K. et al. The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease. Angew. Chem. Int. Ed. Engl. 50, 5889\u20135891 (2011).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"8646_CR15","doi-asserted-by":"publisher","first-page":"e02204","DOI":"10.1128\/AAC.02204-18","volume":"63","author":"MP Choules","year":"2019","unstructured":"Choules, M. P. et al. Rufomycin targets ClpC1 proteolysis in Mycobacterium tuberculosis and M. abscessus. Antimicrob. Agents Chemother. 63, e02204\u2013e02218 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8646_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/AAC.04054-14","volume":"59","author":"W Gao","year":"2015","unstructured":"Gao, W. et al. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. Antimicrob. Agents Chemother. 59, 880\u2013889 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8646_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00419-5","volume":"8","author":"J Ma","year":"2017","unstructured":"Ma, J. et al. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents. Nat. Commun. 8, 391 (2017).","journal-title":"Nat. Commun."},{"key":"8646_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","volume":"21","author":"E Gavrish","year":"2014","unstructured":"Gavrish, E. et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem. Biol. 21, 509\u2013518 (2014).","journal-title":"Chem. Biol."},{"key":"8646_CR19","doi-asserted-by":"publisher","first-page":"659997","DOI":"10.3389\/fcimb.2021.659997","volume":"11","author":"L Victoria","year":"2021","unstructured":"Victoria, L., Gupta, A., G\u00f3mez, J. L. & Robledo, J. Mycobacterium abscessus complex: a review of recent developments in an emerging pathogen. Front. Cell. Infect. Microbiol. 11, 659997 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"8646_CR20","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3389\/fmicb.2018.02179","volume":"9","author":"S Luthra","year":"2018","unstructured":"Luthra, S., Rominski, A. & Sander, P. The role of antibiotic-target-modifying and antibiotic-modifying enzymes in Mycobacterium abscessus drug resistance. Front. Microbiol. 9, 2179 (2018).","journal-title":"Front. Microbiol."},{"key":"8646_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1101\/gr.075069.107","volume":"18","author":"TP Stinear","year":"2008","unstructured":"Stinear, T. P. et al. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res. 18, 729\u2013741 (2008).","journal-title":"Genome Res."},{"key":"8646_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mib.2009.11.006","volume":"13","author":"MU Shiloh","year":"2010","unstructured":"Shiloh, M. U. & Champion, P. A. D. To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?. Curr. Opin. Microbiol. 13, 86\u201392 (2010).","journal-title":"Curr. Opin. Microbiol."},{"key":"8646_CR23","doi-asserted-by":"publisher","first-page":"e0119341","DOI":"10.1371\/journal.pone.0119341","volume":"10","author":"F Yang","year":"2015","unstructured":"Yang, F. et al. Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step. PLoS ONE 10, e0119341 (2015).","journal-title":"PLoS ONE"},{"key":"8646_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08464-y","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model. Nat. Commun. 10, 524 (2019).","journal-title":"Nat. Commun."},{"key":"8646_CR25","doi-asserted-by":"publisher","first-page":"e01881","DOI":"10.1128\/AAC.01881-19","volume":"64","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Assessment of clofazimine and TB47 combination activity against Mycobacterium abscessus using a bioluminescent approach. Antimicrob. Agents Chemother. 64, e01881\u201301819 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8646_CR26","doi-asserted-by":"publisher","first-page":"e29774","DOI":"10.1371\/journal.pone.0029774","volume":"7","author":"T Zhang","year":"2012","unstructured":"Zhang, T., Li, S. Y. & Nuermberger, E. L. Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy. PLoS ONE 7, e29774 (2012).","journal-title":"PLoS ONE"},{"key":"8646_CR27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1128\/IAI.66.2.794-799.1998","volume":"66","author":"M Zhang","year":"1998","unstructured":"Zhang, M., Gong, J., Lin, Y. & Barnes, P. F. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect. Immun. 66, 794\u2013799 (1998).","journal-title":"Infect. Immun."},{"key":"8646_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/acsinfecdis.8b00225","volume":"5","author":"XY Lu","year":"2019","unstructured":"Lu, X. Y. et al. Pyrazolo[1,5-]pyridine inhibitor of the respiratory cytochrome complex for the treatment of drug-resistant tuberculosis. ACS Infect. Dis. 5, 239\u2013249 (2019).","journal-title":"ACS Infect. Dis."},{"key":"8646_CR29","doi-asserted-by":"publisher","first-page":"e29108","DOI":"10.1371\/journal.pone.0029108","volume":"7","author":"I Bergval","year":"2012","unstructured":"Bergval, I. et al. Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro. PLoS ONE 7, e29108 (2012).","journal-title":"PLoS ONE"},{"key":"8646_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/acsinfecdis.8b00276","volume":"5","author":"NM Wolf","year":"2019","unstructured":"Wolf, N. M. et al. High-resolution structure of ClpC1-rufomycin and ligand binding studies provide a framework to design and optimize anti-tuberculosis leads. ACS Infect. Dis. 5, 829\u2013840 (2019).","journal-title":"ACS Infect. Dis."},{"key":"8646_CR31","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"8646_CR32","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","volume":"45","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Pubchem bioassay: 2017 update. Nucleic Acids Res. 45, D955\u2013D963 (2017).","journal-title":"Nucleic Acids Res."},{"key":"8646_CR33","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1128\/AAC.00152-16","volume":"60","author":"GG Makafe","year":"2016","unstructured":"Makafe, G. G. et al. Role of the Cys154Arg substitution in ribosomal protein L3 in Oxazolidinone resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 60, 3202\u20133206 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8646_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02289-24","volume":"13","author":"C Fang","year":"2025","unstructured":"Fang, C. et al. GrcC1 mediates low-level resistance to multiple drugs in M. marinum, M. abscessus, and M. smegmatis. Microbiol Spectr. 13, e0228924 (2025).","journal-title":"Microbiol Spectr."},{"key":"8646_CR35","doi-asserted-by":"publisher","first-page":"30883","DOI":"10.1074\/jbc.M113.493767","volume":"288","author":"D Vasudevan","year":"2013","unstructured":"Vasudevan, D., Rao, S. P. & Noble, C. G. Structural basis of mycobacterial inhibition by cyclomarin A. J. Biol. Chem. 288, 30883\u201330891 (2013).","journal-title":"J. Biol. Chem."},{"key":"8646_CR36","doi-asserted-by":"crossref","unstructured":"Chhotaray, C. et al. Advances in the development of molecular genetic tools for Mycobacterium tuberculosis. J. Genet. Genom. 45, 281\u2013297 (2018).","DOI":"10.1016\/j.jgg.2018.06.003"},{"key":"8646_CR37","doi-asserted-by":"publisher","first-page":"e00947","DOI":"10.1128\/AEM.00947-17","volume":"83","author":"M Yan","year":"2017","unstructured":"Yan, M. et al. CRISPR-Cas12a-assisted recombineering in bacteria. Appl. Environ. Microbiol. 83, e00947\u201300917 (2017).","journal-title":"Appl. Environ. Microbiol."},{"key":"8646_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02809-23","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria. Microbiol Spectr. 11, e0280923 (2023).","journal-title":"Microbiol Spectr."},{"key":"8646_CR39","doi-asserted-by":"publisher","first-page":"e11058","DOI":"10.1371\/journal.pone.0011058","volume":"5","author":"R Dziedzic","year":"2010","unstructured":"Dziedzic, R. et al. Mycobacterium tuberculosis ClpX interacts with FtsZ and interferes with FtsZ assembly. PLoS ONE 5, e11058 (2010).","journal-title":"PLoS ONE"},{"key":"8646_CR40","first-page":"13","volume":"41","author":"J Bai","year":"2021","unstructured":"Bai, J., Chi, M., Hu, Y., Hao, M. & Zhang, X. Construction and biological characteristics of ClpC and ClpX knock-down strains in Mycobacterium smegmatis. China Biotechnol. 41, 13\u201322 (2021).","journal-title":"China Biotechnol."},{"key":"8646_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.274","volume":"2","author":"JM Rock","year":"2017","unstructured":"Rock, J. M. et al. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat. Microbiol. 2, 1\u20139 (2017).","journal-title":"Nat. Microbiol."},{"key":"8646_CR42","doi-asserted-by":"crossref","unstructured":"Vivoli, M., Novak, H. R., Littlechild, J. A. & Harmer, N. J. Determination of protein-ligand interactions using differential scanning fluorimetry. J. Vis. Exp. 13, e51809 (2014).","DOI":"10.3791\/51809"},{"key":"8646_CR43","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1093\/nar\/gkq1149","volume":"39","author":"JH Kim","year":"2011","unstructured":"Kim, J. H. et al. Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase. Nucleic Acids Res. 39, 2210\u20132220 (2011).","journal-title":"Nucleic Acids Res."},{"key":"8646_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.molcel.2006.04.027","volume":"22","author":"KE McGinness","year":"2006","unstructured":"McGinness, K. E., Baker, T. A. & Sauer, R. T. Engineering controllable protein degradation. Mol. Cell 22, 701\u2013707 (2006).","journal-title":"Mol. Cell"},{"key":"8646_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15516-1","volume":"11","author":"P Gopal","year":"2020","unstructured":"Gopal, P. et al. Pyrazinamide triggers degradation of its target aspartate decarboxylase. Nat. Commun. 11, 1661 (2020).","journal-title":"Nat. Commun."},{"key":"8646_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003994","volume":"10","author":"RM Raju","year":"2014","unstructured":"Raju, R. M. et al. Post-translational regulation via Clp protease is critical for survival of Mycobacterium tuberculosis. PLoS Pathog. 10, e1003994 (2014).","journal-title":"PLoS Pathog."},{"key":"8646_CR47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00282-21","volume":"65","author":"GS Shetye","year":"2021","unstructured":"Shetye, G. S., Choi, K. B., Kim, C. Y., Franzblau, S. G. & Cho, S. In vitro profiling of antitubercular compounds by rapid, efficient, and nondestructive assays using autoluminescent Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 65, e0028221 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8646_CR48","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3389\/fmicb.2018.01145","volume":"9","author":"AV Guti\u00e9rrez","year":"2018","unstructured":"Guti\u00e9rrez, A. V., Viljoen, A., Ghigo, E., Herrmann, J.-L. & Kremer, L. Glycopeptidolipids, a double-edged sword of the Mycobacterium abscessus complex. Front. Microbiol. 9, 1145 (2018).","journal-title":"Front. Microbiol."},{"key":"8646_CR49","doi-asserted-by":"publisher","first-page":"MGM2","DOI":"10.1128\/microbiolspec.MGM2-0013-2013","volume":"2","author":"M Jankute","year":"2014","unstructured":"Jankute, M., Grover, S., Birch, H. L. & Besra, G. S. Genetics of mycobacterial arabinogalactan and lipoarabinomannan assembly. Microbiol. Spectr. 2, MGM2\u2013MGM2013 (2014).","journal-title":"Microbiol. Spectr."},{"key":"8646_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14731","volume":"8","author":"L Botella","year":"2017","unstructured":"Botella, L., Vaubourgeix, J., Livny, J. & Schnappinger, D. Depleting Mycobacterium tuberculosis of the transcription termination factor Rho causes pervasive transcription and rapid death. Nat. Commun. 8, 14731 (2017).","journal-title":"Nat. Commun."},{"key":"8646_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0022-2836(88)90573-6","volume":"204","author":"DJ Jin","year":"1988","unstructured":"Jin, D. J. et al. Effects of rifampicin resistant rpoB mutations on antitermination and interaction with nusA in Escherichia coli. J. Mol. Biol. 204, 247\u2013261 (1988).","journal-title":"J. Mol. Biol."},{"key":"8646_CR52","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1365-2958.2010.07232.x","volume":"77","author":"JG Sklar","year":"2010","unstructured":"Sklar, J. G., Makinoshima, H., Schneider, J. S. & Glickman, M. S. M. tuberculosis intramembrane protease Rip1 controls transcription through three anti-sigma factor substrates. Mol. Microbiol. 77, 605\u2013617 (2010).","journal-title":"Mol. Microbiol."},{"key":"8646_CR53","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa, A. N., Subbian, S., Hanna, L. E. & Selvakumar, N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect. Genet. Evol. 45, 474\u2013492 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"8646_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","volume":"8","author":"HA Hameed","year":"2018","unstructured":"Hameed, H. A. et al. Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains. Front. Cell. Infect. Microbiol. 8, 114 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"8646_CR55","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1128\/AAC.47.4.1241-1250.2003","volume":"47","author":"SV Ramaswamy","year":"2003","unstructured":"Ramaswamy, S. V. et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47, 1241\u20131250 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8646_CR56","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1128\/IAI.66.11.5099-5106.1998","volume":"66","author":"P Chen","year":"1998","unstructured":"Chen, P. & Bishai, W. R. Novel selection for isoniazid (INH) resistance genes supports a role for NAD+-binding proteins in mycobacterial INH resistance. Infect. Immun. 66, 5099\u20135106 (1998).","journal-title":"Infect. Immun."},{"key":"8646_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.tube.2014.12.002","volume":"95","author":"L He","year":"2015","unstructured":"He, L. et al. ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis. Tuberculosis 95, 149\u2013154 (2015).","journal-title":"Tuberculosis"},{"key":"8646_CR58","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.apsb.2020.11.007","volume":"11","author":"Y Gao","year":"2021","unstructured":"Gao, Y. et al. Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans. Acta Pharm. Sin. B. 11, 738\u2013749 (2021).","journal-title":"Acta Pharm. Sin. B."},{"key":"8646_CR59","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1021\/acs.jnatprod.1c00198","volume":"84","author":"B Zhou","year":"2021","unstructured":"Zhou, B. et al. Rufomycins or Ilamycins: naming clarifications and definitive structural assignments. J. Nat. Prod. 84, 2644\u20132663 (2021).","journal-title":"J. Nat. Prod."},{"key":"8646_CR60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/febs.15335","volume":"288","author":"M Ziemski","year":"2021","unstructured":"Ziemski, M., Leodolter, J., Taylor, G., Kerschenmeyer, A. & Weber-Ban, E. Genome-wide interaction screen for Mycobacterium tuberculosis ClpCP protease reveals toxin-antitoxin systems as a major substrate class. FEBS J. 288, 111\u2013126 (2021).","journal-title":"FEBS J."},{"key":"8646_CR61","doi-asserted-by":"publisher","first-page":"691399","DOI":"10.3389\/fmolb.2021.691399","volume":"8","author":"P Bordes","year":"2021","unstructured":"Bordes, P. & Genevaux, P. Control of toxin-antitoxin systems by proteases in Mycobacterium tuberculosis. Front. Mol. Biosci. 8, 691399 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"8646_CR62","doi-asserted-by":"publisher","first-page":"e00338","DOI":"10.1128\/mSphere.00338-16","volume":"2","author":"Y Yamada","year":"2017","unstructured":"Yamada, Y. & Dick, T. Mycobacterial caseinolytic protease gene regulator ClgR is a substrate of caseinolytic protease. mSphere 2, e00338\u201300316 (2017).","journal-title":"mSphere"},{"key":"8646_CR63","doi-asserted-by":"publisher","first-page":"17724","DOI":"10.1073\/pnas.0601505103","volume":"103","author":"G Thibault","year":"2006","unstructured":"Thibault, G. et al. Specificity in substrate and cofactor recognition by the N-terminal domain of the chaperone ClpX. Proc. Natl Acad. Sci. USA 103, 17724\u201317729 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8646_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00433-24","volume":"69","author":"Y Ju","year":"2025","unstructured":"Ju, Y. et al. The gene MAB_2362 is responsible for intrinsic resistance to various drugs and virulence in Mycobacterium abscessus by regulating cell division. Antimicrob. Agents Chemother. 69, e0043324 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8646_CR65","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.4014\/jmb.1905.05006","volume":"29","author":"H Jiang","year":"2019","unstructured":"Jiang, H. et al. One-step engineering of a stable, selectable marker-free autoluminescent Acinetobacter baumannii for rapid continuous assessment of drug activity. J. Microbiol. Biotechnol. 29, 1488\u20131493 (2019).","journal-title":"J. Microbiol. Biotechnol."},{"key":"8646_CR66","doi-asserted-by":"publisher","first-page":"112919","DOI":"10.1016\/j.bios.2020.112919","volume":"177","author":"X Tian","year":"2021","unstructured":"Tian, X. et al. Rapid visualized assessment of drug efficacy in live mice with a selectable marker-free autoluminescent Klebsiella pneumoniae. Biosens. Bioelectron. 177, 112919 (2021).","journal-title":"Biosens. Bioelectron."},{"key":"8646_CR67","doi-asserted-by":"publisher","first-page":"112396","DOI":"10.1016\/j.bios.2020.112396","volume":"165","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Rapid, serial, non-invasive quantification of Pseudomonas aeruginosa in live mice with a selectable marker-free autoluminescent strain. Biosens. Bioelectron. 165, 112396 (2020).","journal-title":"Biosens. Bioelectron."},{"key":"8646_CR68","doi-asserted-by":"publisher","first-page":"110782","DOI":"10.1016\/j.biopha.2020.110782","volume":"131","author":"W Yu","year":"2020","unstructured":"Yu, W. et al. TB47 and clofazimine form a highly synergistic sterilizing block in a second-line regimen for tuberculosis in mice. Biomed. Pharmacother. 131, 110782 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"8646_CR69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejmech.2018.11.054","volume":"163","author":"P Liu","year":"2019","unstructured":"Liu, P. et al. Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents. Eur. J. Med. Chem. 163, 169\u2013182 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"8646_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/life13010031","volume":"13","author":"R Khadiullina","year":"2022","unstructured":"Khadiullina, R. et al. Assessment of thermal stability of mutant p53 proteins via differential scanning fluorimetry. Life13, 31 (2022).","journal-title":"Life"},{"key":"8646_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58410-4","volume":"16","author":"B Zhou","year":"2025","unstructured":"Zhou, B. et al. Structural insights into bortezomib-induced activation of the caseinolytic chaperone-protease system in Mycobacterium tuberculosis. Nat. Commun. 16, 3466 (2025).","journal-title":"Nat. Commun."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08646-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08646-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08646-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:54:20Z","timestamp":1757382860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08646-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8646"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08646-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1219"}}